Xia & He Publishing Inc. Nov 27 2024 Cardiovascular diseases remain a leading cause of mortality globally, particularly among individuals with both obstructive sleep apnea (OSA) and metabolic syndrome (MetS). These two conditions exacerbate each other, creating a vicious cycle that increases the risk of cardiovascular diseases. Understanding the pathophysiological relationship between OSA and MetS is crucial for developing effective prevention and treatment strategies. This review explores